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Objective: To determine alterations in quantities and distributions of natural antimi-
crobials following ischemia-reperfusion injury. We hypothesized that these compounds
would be upregulated in areas of small intestine where changes in permeability and
cellular disruption were likely and where protective mechanisms would be initiated.
Methods: Rats with ischemia-reperfusion underwent superior mesenteric artery clamp-
ing and reperfusion. Shams were subjected to laparotomy but no clamping. Ileum and
jejunum were harvested and sectioned, and subjected to fluorescence deconvolution mi-
croscopy for determinations of content and localization of rat beta defensins, 1, 2, 3;
rat neutrophil protein-1; and cathelicidin LL-37. Modeling was performed to determine
cellular location of antimicrobials. Results: Ischemia-reperfusion increased neutrophil
defensin alpha (RNP-1) in jejunum; rat beta defensin 1 was increased 2-fold in ileal
mucosa and slightly reduced in jejunal mucosa; rat beta defensin 2 was reduced by
ischemia-reperfusion in ileum, but slightly increased in jejunum; rat beta defensin 3 was
concentrated in the muscularis externa and myenteric plexus of the jejunum; ischemia-
reperfusion did not alter cathelicidin LL-37 content in the small intestine, although a
greater concentration was seen in jejunum compared with ileum.Conclusion: Ischemia-
reperfusion injury caused changes in antimicrobial content in defined areas, and these
different regulations might reflect the specific roles of jejunum versus ileum.
Intestinal mucosa is very susceptible to ischemia-reperfusion (I/R) initiated changes
that are often seen after shock and small-bowel transplantation. Previous work has shown
major consequences of intestinal I/R injury, such as changes in gene expression patterns,
altered levels of component calcium handling proteins, and cytoskeletal disruption.1-3 Our
hypothesis was that as areas and cells of the small intestine were traumatized, protective
mechanisms would be initiated, and that one of these mechanisms would be increases in
defensin content in specific layers of the tissue.4
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Sloughing of cells following substantial blebbing due to prolonged ischemia has been
reported as a nonreversible injury, such that rates and amounts of cell destruction need to be
determined to understand the temporal aspects of cell loss and necrosis in order to initiate
protective, rather than recovery, therapies.5 Hemorrhage in the mesentery causes increased
concentrations of not only proinflammatory cytokines, but also anα-defensin product, while
intestinal I/R results in increased levels of β-defensin 2, possibly as a protective factor to
combat acute lung injury due to increased levels of tumor necrosis factor α.6,7 It is evident
that defensins have a significant role in the protection of various tissues including the
intestine.8 However, it has also been reported that enteric defensins are intimately involved
in microbial regulation as well as having individual, distinct roles in defined areas of the
gastrointestinal tract, a finding we have seen before and also report here.9 Furthermore,
we report differences regarding changes in peptide content due to I/R, not unlike those
observations regarding β-defensin induction due to numerous diseases and hemorrhagic
shock.4,10-14
Our previous studies investigating heart failure led us to believe that defensins were
largely associated with vascular endothelial cells, a localization noted by others.13 It is
not surprising, therefore, that the images acquired in this study also indicate an intimate
relationship of peptides with vascular elements of the small intestine. We studied these
particular defensins aswe have seen concentration and localization changes in these peptides
associated with burn injury, and others have reported alterations in β-defensin expression
with intestinal problems,7,8,11,12 and because of a recent publication regarding mucosal
immunity.8
The results suggest that not only are defensins in a position to combat the invasion of
bacteria from the intestinal lumen but also to counteract circulating microbes and, as such,
have at least a role in a 2-pronged defense.
METHODS
All chemicals were purchased from Sigma Chemical Corp, (St Louis, Mo) except where
stated, and are of the highest grade available.
Animal Surgery
All procedures and protocols were approved by the University of Texas Houston Medical
School Animal Welfare Committee. Male Sprague-Dawley rats weighing 250 to 300 g
were obtained and housed individually. They were kept at room temperature (25◦C) with
alternating 12-hour light/dark cycles. Animals were fed standard rat chow and water ad
libitum during a minimum acclimation period of 5 days. Each animal was fasted with free
access to water overnight before laparotomy. Operative procedures were performed using
sterile techniques under general anesthesia with isoflurane-inhaled anesthetic.
Amidline laparotomywasmade, and the gut I/Rwas carried out by superiormesenteric
artery occlusion for 60 minutes. After removal of the clamp, the incision was closed and the
rats were allowed to awaken and were observed for 6 hours. Sham animals underwent an
identical procedure but without placement of the clamp on the superiormesenteric artery. At
the end of 6 hours, animals were sacrificed under isoflurane anesthesia by exsanguination,
59
ePlasty VOLUME 11
and full thickness segments of jejunum 5 cm distal to the ligament of Treitz and ileum, 2 cm
proximal to the cecum, were harvested. These measurements were always used to assure
that tissues sectioning was consistent.
Tissue Preparation
After surgery, tissue samples from ileumand jejunumwere removed immediately, embedded
in sucrose-based O.C.T. compound (Tissue-Tek, Torrance, Calif) and frozen on dry ice.
Processing of samples and methodology for fluorescence deconvolution microscopy have
been presented and discussed in detail.2,3,11 Briefly, frozen sections were cut to a thickness
of 12 ± 3 μm with a cryotome (Microm HM 505 E, Microm Laboratories, Walldorf,
Germany) and placed on 18-mm, acid-cleaned, glass cover slips (Fisher, Pittsburgh, Pa),
coated with poly-L-lysine. Sections were rinsed with cold phosphate buffered saline, fixed
in 3.7% paraformaldehyde (Tousimis Research, Rockville, Md) at room temperature, and
rinsed 5 timeswith phosphate buffered saline at room temperature. Cover slipswere inverted
and floated on 10% goat serum for 1 hour at 37◦C to reduce nonspecific antibody binding,
then antibodies against the defensins β-defensin 1, β-defensin 2, neutrophil defensin NP-1
(Alpha Diagnostic, San Antonio, Tex), β-defensin 3 (Novus Biologicals, Littleton, Colo),
cathelicidin LL-37 (Hycult Biotechnology b.v., Uden, the Netherlands), and smooth muscle
actin (Sigma, St Louis, Mo) were diluted 1:100 in 10% goat serum and incubated with
tissue sections for 45 minutes at 37◦C. After rinsing the coverslips in 0.05% Tween20,
fluorescently tagged secondary antibodies (Molecular Probes, Eugene, Ore) were added
and the sections were incubated for 30 minutes at 37◦C. Finally, F-Actin and the nuclei
were simultaneously stained with phallacidin and 4′, 6-diamidino-2-phenylindole (DAPI),
respectively (Molecular Probes, Eugene, Ore) for 15 minutes at room temperature. Cover
slips were mounted onto glass slides with Elvanol antifade (DuPont, Wilmington, Del) and
attached with nail polish.
Reconstructive Microscopy (Deconvolution)
Three portions of ileum and jejunum were taken from each of 3 I/R and 3 sham animals,
and 3 sections from each portion were taken. Three scans were performed on each section
giving a total of 81 data acquisitions per group. Specimens were scanned with an Applied
Precision DeltaVision (Issaquah, Wash) system fitted with an Olympus IX 70 inverted
microscope employing a 100-W mercury arc lamp for illumination (Olympus America,
Melville, NY), and excitation/emission filter sets (Chroma Technology Corp, Brattleboro,
Vt) specific for each of the fluorescent antibodies. Filter-set combinations were set for each
probe as follows: DAPI (nucleus), 340-nm excitation filter (band-pass of 20 nm), and an
emission filter of 390 nm (band-pass of 20 nm); Phallicidin (F-Actin), excitation filter of
488 nm (band-pass 10 nm), and an emission filter of 520 nm (band-pass 25 nm); defensin
antibodies, excitation filter of 555 nm (band-pass 28 nm), and an emission filter of 617
nm (band-pass 73 nm); and smooth muscle actin, excitation filter of 640 nm (band-pass
20 nm), and emission filter of 685 nm (band pass of 40 nm). Image scans for each probe
were acquired in series at a step size of 0.35 μm with a Sony Interline CCD camera
(Sony Corp., New York, NY). At least 30 sections were scanned per sample for each
probe. Deconvolution and image analysis were performed by transferring the data sets to
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a Linux/RedHat workstation employing SoftWoRx software (Applied Precision, Issaquah,
WA) using an algorithm experimentally produced on the system from the convolution of a
point-spread function to differentiate and reduce extraneous light or scattered light captured
by the camera, derived by scanning a 0.1 μm fluorescent bead (Molecular Probes, Eugene,
Ore) 4 μm above and 4 μm below the plane of focus. The resulting point-spread function
is Fourier transformed into an optical transfer function that uses the data to produce images
with a higher signal-to-noise resolution of the probe emission patterns. All data sets are
subjected to 5 to 15 deconvolution iterations and then analyzed, reconstructed, volume
rendered, and modeled. Subtraction of background fluorescence and change of intensity
gain were optimally set for each emission.
An image projection is produced by stacking each of the individual z-sections of
the acquisition into one image, resulting in a 3-dimensional image with overlaid colors.
Volume rendering uses these z-section stacks and rotates them about the X or Y plane and a
3-dimensional, computer-generated, virtual model of the fluorescence emission patterns is
produced to view relative positions of each emission/probe and determine the localization
of defensins to specific cells types and tissue areas.2 The 3-dimensional model is fully
interactive and can be rotated in any plane for viewing at any angle or perspective.
RESULTS
Figure 1 includes 2 pairs of images (control-shams on the left, I/R tissues on the right)
and compares and contrasts the content and localization of rat beta defensin (RBD)-1 in
the ileum of control (A) and I/R (B) animals (magnification X 400). Panels C and D are
cut-out sections at a higher magnification (X 1200) to show that enterocytes contained more
peptide after I/R, with high concentrations of RBD-1 in and around the central lacteal area
of these villi both before and after I/R injury.
To further show the regulations and specificities, Figure 2 includes 6 pairs of images
(shams on the left and I/R samples on the right). In each of the panels, the antimicrobial
peptide is shown in red (orange/yellow where colocalization occurs). Cell nuclei are blue
and F-actin is green. The first pair (panel A) are the images from Figure 1, but of note
here is the high concentration of RBD-1 seen in the lower portion of the villi in the I/R
sample. Panel B also shows RBD-1, but in the lower portion of the mucosa, where the
crypts meet the glands. Note the increased amount of (red) peptide following I/R. Panel
C is of RBD-3, located at an extremely high concentration in the longitudinal layer of
the muscularis externa, but greatly reduced following I/R. However, this loss is somewhat
compensated for by an increase in the inner, circular layer of the externa and maybe even
in the myenteric plexus. Panel D demonstrates that I/R injury shows a trend of increasing
RBD-2 in luminal epithelial cells in jejunum as seen in this pair of images, but not in ileum.
Overall, the values are not significantly different; however, as stated, the trend within pairs
is for an increase in staining intensity as shown here (13300 ± 7889 vs 16123 ± 7066;
sham vs I/R pixels). Panel E shows that there was no change (18938 ± 8607 vs 18245
± 7168; sham vs I/R; pixels) when comparing concentrations of RNP-1. The final pair of
images, panel F, shows that LL-37 was also found predominantly in the outer muscularis
externa, as was RBD-3, and that the amount was dramatically reduced by I/R, while this
loss was compensated for by a dramatic increase in the lower gland cells, in the area one
would expect to find Paneth cells, of the mucosa.
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Figure 1. Comparison of the content and localization of rat beta defensin 1 in the ileum of control
(panel A) and ischemia-reperfusion (panel B) animals. Panels C and D are cut-out sections at a
higher magnification to show the extent of antimicrobial “filling” of the surface enterocytes. Also of
note is the defensin (red) associated with the central area of the villus. Magnification (panels A and
B) X 400; magnification (panels C and D) X 900. F-actin is green, nuclei are blue. Deconvolution
iterations 15.
Overall, even though total peptide content of small intestine samples might not appear
to change in many sections, changes in specific components of full thickness sections did
indeed show dramatic differences. Also, a general rule could be applied in that the ileum
showed an increase, or at least no decrease, in peptide content following I/R, while the
jejunum revealed slight decreases.
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Figure 2. This figure demonstrates the specificities with regard to both concentration changes and
localizations of various antimicrobials in the ileum. Each pair of images (panels A through F) shows
the sham tissue on the left and the ischemia-reperfusion image on the right. The first 2 panels (A) are
images used to produce Figure 1. More rat beta defensin (RBD)-1 is seen in the apical and middle
regions of the villi. Panel B again showsRBD-1 (red), but this time in the base/neck region of the villi.
Panel C shows RBD-3 before and after ischemia-reperfusion demonstrating a decrease in peptide in
the outer, longitudinal muscularis externa and a small increase in the inner, circular layer. Panel D
shows RBD-2 increase in enterocytes due to I/R and a decrease in perilacteal concentration. Panel E
shows RNP-1 throughout the epithelial layer of both sham and ischemia-reperfusion samples; panel
F clearly demonstrates a reduction of cathelicidin in the outer, longitudinal muscularis externa, but
an increase in the lower, glandular aspects of the mucosa (magnification X 400).
Panel A in Figure 3 demonstrates the very high concentration and specific localization
of RBD-2 (red) in this sample of I/R jejunum, while in I/R ileum (image B), the RBD-2 is
found throughout the epithelium, even into the neck and lower glands. Panel C is a high-
power image cut out of I/R jejunum, to demonstrate the central concentrations of peptide,
(identifiable as both red and white due to colocalization with green probe) localized with
the smooth muscle actin of the small vessels (magnification X 1200).
Figure 4 shows models constructed by image stacking, as described under “Methods”
section, of sham jejunum (panel A) and I/R jejunum (panel B) to show the distinct changes at
defined levels. The upper blue arrow points to the increase in RBD-2 (red) in the enterocyte,
adjacent to a goblet cell, following I/R, while the lower blue arrow points to the decrease
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in RBD-2 in the central-lacteal region of these villi, following I/R injury. The small inserts
show the stacked images from which the models were generated. Nuclei are blue, F-actin
is green.
To show theses specificities, we prepared some cropped images and measured pixel
densities to compare against full thickness images, while also comparing tissue, ileum
versus jejunum, and peptide content (Table 1). As can be seen, RBD-1 content in ileum was
increased following I/R, while it was decreased in jejunum. In contrast, RNP-1 content in
jejunum was increased, while in ileum, it remained unchanged. Cropping sections (Table 1,
part B) also revealed that localizations such as RBD-3 in ileum was found mostly in the
externa (see Fig 2, panel C), while in the sham jejunum, it was very apparent in themyenteric
plexus and was decreased following I/R.
Figure 3. Panel A shows very high concentration of rat beta defensin 2 (red) in specific areas of
this sample of I/R jejunum, while in I/R ileum (image B), rat beta defensin 2 is seen in surface
epithelium, neck region and lower glands. Panel C shows high-power (magnification X 1200) cut out
from panel A to demonstrate the central concentrations of peptide that show as both red and white
areas, the latter due to colocalization with smooth muscle actin of the small vessels (magnification
X 400).
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Figure 4. Models constructed by image stacking, as described under “Methods” section, of sham
jejunum (panel A) and ischemia-reperfusion jejunum (panel B) to detail changes in specific areas.
The upper blue arrow points to increased rat beta defensin 2 (red) in this enterocyte, adjacent
to a goblet cell, following ischemia-reperfusion; the lower blue arrow indicates rat beta defensin
2 in the central-lacteal region of this villus, following ischemia-reperfusion. The small inserts
show the stacked images from which the models were generated. Nuclei are blue, F-actin is green
(magnification X 400).
DISCUSSION
Defensins are small cationic peptides that are important components of the innate im-
mune system especially in intestinal defense,15-18 and there are many reports that defensins
have more than just an antitoxin role. Although this report is of a nonfunctional, mor-
phological study, it does support previous findings of specificities among antimicrobial
peptides as to their role(s) in protection and we wanted to determine whether antimicro-
bial peptides were possibly part of the injury process, becoming a barrier against ensuing
toxic events. A recent report suggested that human β-defensin 2 has a chemotactic affect
with regard to endothelial cells and might well be proangiogenic and this possibility fits
nicely with our finding of colocalization of defensins to capillaries and the microvascu-
lature in the lacteals, myenteric plexus, muscularis externa, and adventitia seen in our
images.11,19
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Table 1. Comparison of Peptide Content in Specific Layers of the Small Intestine in Ileum Versus
Jejunum and Sham Versus I/R Tissues
Sham I/R Trend
Tissue Peptide Pixels Pixels
Ileum RBD-1 5377 ± 2181 1028613705 Up*
Jejunum RBD-1 1048611751 736611542 Down†
Ileum RNP-1 1893818607 1824517168 No change
Jejunum RNP-1 1599615295 1959517544 Up‡
PART B
Sham Action Conclusion
Tissue Peptide Pixels Pixels
Ileum RBD-3 1662715297 Remove externa 436711778 Much in externa§
Jejunum RBD-3 1395213446 Remove externa and Auerbach’s 616112394 Much in Auerbach’s|
I/R indicates ischemia-reperfusion; RBD, rat beta defensin.
*P < .05 I/R versus sham.
†P < .05 sham versus I/R.
‡P < .10 I/R versus sham.
§P < .01 with externa versus without externa.
|P < .01 with externa versus without externa.
Using deconvolution microscopy, we have shown that defensins are in certain cells
and areas, and put forward suggestions as to the functional diversity of the antimicrobial
peptides. We chose to examine the particular peptides noted in this work because of
their continued appearance in the literature concerning intestinal well-being, and although
our observations with cathelicidin LL-37 pose a bit of a quandary, this peptide having
previously been associated only with epithelial cells of the colon, Termen et al did report
the rat cathelicidin rCRAMP being identified in small intestine.20-22 It is, therefore, evident
that multiple mechanisms and compounds are employed to combat bacterial infection and,
more importantly, bacterial entry into underlying tissues.
Reported research as to the foci of specific antimicrobials lends evidence to particular
functions as suggested by our findings. For example, LL-37was found in high concentrations
in the apical portions of many villi following I/R, possibly pointing to its role in enhanced
endothelial proliferation23 as well as in cell protection and healing effects.24,25 The finding
of LL-37 in the outer externa, adventitia, and serosa also suggests that it might exert its
reported angiogenic effects in these areas, overcoming or delaying necrotic and apoptotic
cell death.24
It has been noted that an understanding of the mechanisms, roles, and targets of in-
dividual antimicrobials in maintaining the delicate balance of retaining endogenous flora
versus eliminating exogenous pathogens is necessary to develop therapeutic strategies in
treating intestinal ailments and replenishing the endothelium.25 A relatively recent review
strengthened the need for understanding the mechanisms and cellular locations of the mul-
tiple defensins and cathelicidins found in the gastrointestinal tract, noting that advances
in new therapies can be made if we do indeed have insights into the roles and mecha-
nisms of these peptides.26 A more recent report stressed the “multilayered regulation” of
66
KOZAR ET AL
gastrointestinal defense, and our findings of specific geographic locations of inducible de-
fensins and intimate associations with particular cell types, yields a better understanding
of potential therapeutic targets in overcoming intestinal inflammation, destruction, and cell
loss while adding further understanding to the “biology of defensins and LL-37,” as well as
“beginning to clarify the pathophysiology of mucosal and infectious diseases.”27−31 Further
elucidation of regulatory changes associated with chronic inflammatory and debilitating
diseases will allow us to not only target appropriate sites and tissues, but will arm us with
an understanding of when to initiate specific therapies and even give us less traumatic
methods for ensuring intestinal well-being.30,31 The apparent specific roles for defensins
with regard to position and protection at luminal epithelium and endothelium, be that of the
vasculature or lining the gut lumen, is a somewhat novel finding, and although publications
of vasculature endothelium localization have been forthcoming, that data are because of
cancer formation.32,33
There are concerns with the work. The number of animals was relatively small; how-
ever, the number of data acquisition points was large. It is also possible that there is cross-
reaction of antibodies and probes, particularly with regard to rat cathelicidin (CRAMP) and
its lack of homology with other cathelicidins. However, a previous report did show specific
staining.11 Future studies should probably use antibodies raised against rat cathelicidin, but
this might be difficult to achieve due to financial constraints.
CONCLUSION
Although this study is observational, the quantity measurements by different methods
does show that different peptides reside in different layers of the intestine, and these
findings lead us to our conclusions that in diverse tissues, defensins are found in both
luminal epithelium and blood vessel epithelium at a time when severe damage to tis-
sue integrity and cell function is imminent. In areas that require increased protection,
this is an important factor in times of gastrointestinal tract infection, ischemia, and
sepsis and leads us to consider antimicrobial upregulation maneuvers as a means of
therapy.
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